Cutler Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Cutler Group’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-131	Closed	–	–	5828
2021 Q3	$0	Buy	+131	New	+$1.04K	﹤0.01%	6136

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

AEPBI

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cutler Group's NAUT Position: Q4 2021 in Review

Cutler Group sold out of Nautilus Biotechnolgy (NAUT) in Q4 2021, closing a stake of 131 shares.

Cutler Group first reported a position in NAUT in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q4 2021.

Cutler Group reported no remaining Nautilus Biotechnolgy position as of Q4 2021 after selling out during the quarter.
Cutler Group sold 131 Nautilus Biotechnolgy shares in Q4 2021.
Cutler Group first reported a position in Nautilus Biotechnolgy in Q3 2021 and held it in 1 quarter.
Cutler Group's Nautilus Biotechnolgy position peaked at $0 in Q3 2021.
81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.